Back to Search
Start Over
Role of heparanase in sepsis-related acute kidney injury (Review).
- Source :
-
Experimental & Therapeutic Medicine . Aug2023, Vol. 26 Issue 2, p1-11. 11p. - Publication Year :
- 2023
-
Abstract
- Sepsis-related acute kidney injury (S-AKI) is a common and significant complication of sepsis in critically ill patients, which can often only be treated with antibiotics and medications that reduce S-AKI symptoms. The precise mechanism underlying the onset of S-AKI is still unclear, thus hindering the development of new strategies for its treatment. Therefore, it is necessary to explore the pathogenesis of S-AKI to identify biomarkers and therapeutic targets for its early diagnosis and treatment. Heparanase (HPA), the only known enzyme that cleaves the side chain of heparan sulfate, has been widely studied in relation to tumor metabolism, procoagulant activity, angiogenesis, inflammation and sepsis. It has been reported that HPA plays an important role in the progression of S-AKI. The aim of the present review was to provide an overview of the function of HPA in S-AKI and to summarize its underlying molecular mechanisms, including mediating inflammatory response, immune response, autophagy and exosome biogenesis. It is anticipated that emerging discoveries about HPA in S-AKI will support HPA as a potential biomarker and therapeutic target to combat S-AKI. [ABSTRACT FROM AUTHOR]
- Subjects :
- *ACUTE kidney failure
*HEPARANASE
*HEPARAN sulfate
*DRUG target
*CRITICALLY ill
Subjects
Details
- Language :
- English
- ISSN :
- 17920981
- Volume :
- 26
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Experimental & Therapeutic Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 169722118
- Full Text :
- https://doi.org/10.3892/etm.2023.12078